“Life sciences” is a common name of a raft of sciences dealing with living organisms and various types of life processes. The life sciences industry can be divided into several sub-groups such as Biotech & Pharma, healthcare, medical devices, research and lab services. Pharmaceuticals form the largest market sector; its sales are predicted to override USD 1 trillion by 2015.
The life sciences market proved to be rather resistant to unfavorable economic conditions. It has experienced healthy growth over the recent years on the back of the population increase, ongoing technological advancements and rising awareness of healthcare. Drug discovery, medical equipment and regenerative medicine represent the most promising market sectors.
A wealthy collection of the research reports providing extensive overview of the life sciences market is at hand in this MarketPublishers’ catalogue. Current situation and historic development of the market are reviewed in the researches. The reports thoroughly examine market segments, disclose essential information on the market size and characterize the industry dynamics and identify major forces shaping the market. Moreover, the long-term and short-term future outlooks for the market can be found in the research reports.
Publications found:
253,269
Sort by:
Giant Cell Arteritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major giant cell arteritis markets reached a value of US$ 1,130.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,825.2 Million by 2034, exhibiting a growth rate (CA...
May 2024
139 pages
Glomerulonephritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major glomerulonephritis markets reached a value of US$ 748.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,105.0 Million by 2034, exhibiting a growth rate (CAGR)...
May 2024
140 pages
Head and Neck Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major head and neck cancer markets reached a value of US$ 3,252.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7,279.8 Million by 2034, exhibiting a growth rate (CA...
May 2024
134 pages
Heart Failure Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The heart failure market reached a value of US$ 6.6 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 18.5 Billion...
May 2024
133 pages
Helicobacter Pylori Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major helicobacter pylori markets reached a value of US$ 3,480.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,891.7 Million by 2034, exhibiting a growth rate (CAG...
May 2024
129 pages
Hemiplegia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major hemiplegia markets reached a value of US$ 710 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,040 Million by 2034, exhibiting a growth rate (CAGR) of 3.57% dur...
May 2024
130 pages
Hemophilia A Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major hemophilia A markets reached a value of US$ 10,288.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 28,447.2 Million by 2034, exhibiting a growth rate (CAGR) of...
May 2024
131 pages
Hemorrhoids Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The hemorrhoids market has been comprehensively analyzed in IMARC's new report titled 'Hemorrhoids Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034'. Hem...
May 2024
137 pages
Hepatic Cirrhosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The hepatic cirrhosis market has been comprehensively analyzed in IMARC's new report titled 'Hepatic Cirrhosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 202...
May 2024
137 pages
Hepatitis A Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The hepatitis A market reached a value of US$ 588.6 Million across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 760.2 Million...
May 2024
135 pages
Hepatitis B Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The hepatitis B market reached a value of US$ 3.3 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 4.9 Billion by...
May 2024
134 pages
Hepatocellular Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major hepatocellular carcinoma markets reached a value of US$ 780 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,520 Million by 2034, exhibiting a growth rate (CAGR...
May 2024
138 pages
